Related references
Note: Only part of the references are listed.A phase I study of concurrent chemoradiotherapy with S-1 for T2N0 glottic carcinoma
Hiroyuki Tsuji et al.
ONCOLOGY (2006)
S-1, an oral fluoropyrimidine anti-cancer agent, enhanced radiosensitivity in a human oral cancer cell line in vivo and in vitro: involvement possibility of inhibition of survival signal, Akt/PKB
K Harada et al.
CANCER LETTERS (2005)
Combined effects of the oral fluoropyrimidine anticancer agent, S-1 and radiation on human oral cancer cells
K Harada et al.
ORAL ONCOLOGY (2004)
Concurrent chemotherapy and radiotherapy for organ preservation in advanced laryngeal cancer
AA Forastiere et al.
NEW ENGLAND JOURNAL OF MEDICINE (2003)
Intergroup phase III comparison of standard radiation therapy and two schedules of concurrent chemoradiotherapy in patients with unresectable squamous cell head and neck cancer
DJ Adelstein et al.
JOURNAL OF CLINICAL ONCOLOGY (2003)
Choosing a concomitant chemotherapy and radiotherapy regimen for squamous cell head and neck cancer: A systematic review of the published literature with subgroup analysis
GP Browman et al.
HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK (2001)
Share Paper
